Compare KNSA & UTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KNSA | UTF |
|---|---|---|
| Founded | 2015 | 2004 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.4B |
| IPO Year | 2018 | N/A |
| Metric | KNSA | UTF |
|---|---|---|
| Price | $38.58 | $24.41 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $51.33 | N/A |
| AVG Volume (30 Days) | ★ 510.1K | 171.7K |
| Earning Date | 02-24-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.19% |
| EPS Growth | N/A | N/A |
| EPS | 0.47 | ★ 2.84 |
| Revenue | ★ $597,973,000.00 | $138,636,669.00 |
| Revenue This Year | $61.60 | N/A |
| Revenue Next Year | $29.82 | N/A |
| P/E Ratio | $88.08 | ★ $9.16 |
| Revenue Growth | ★ 55.68 | 19.80 |
| 52 Week Low | $17.82 | $22.05 |
| 52 Week High | $44.42 | $26.53 |
| Indicator | KNSA | UTF |
|---|---|---|
| Relative Strength Index (RSI) | 36.23 | 56.57 |
| Support Level | $39.16 | $23.86 |
| Resistance Level | $43.00 | $24.50 |
| Average True Range (ATR) | 1.70 | 0.26 |
| MACD | -0.29 | 0.03 |
| Stochastic Oscillator | 6.41 | 84.42 |
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
Cohen & Steers Infrastructure Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is total return with an emphasis on income. It invests majority of its managed assets in securities issued by infrastructure companies, which consists of utilities, pipelines, toll roads, airports, railroads, ports, telecommunications companies, and other infrastructure companies, under normal market conditions.